Ian Chan

Ian Chan is recorded as CEO at Abpro Holdings, Inc. (ABPO) since November 13, 2024 and Board Member at Abpro Holdings, Inc. (ABPO) since January 1, 2024. The newest filing on record that lists Ian Chan as Board Member at Abpro Holdings, Inc. (ABPO) is dated September 8, 2025. Abpro Holdings, Inc. reported in an 8-K filed March 7, 2025 that Ian Chan was terminated as Chief Executive Officer and principal executive officer, effective March 3, 2025. Abpro Holdings, Inc. reported in an 8-K filed November 26, 2024 that Ian Chan was appointed Chief Executive Officer and Director, effective November 13, 2024. The proxy statement of Abpro Holdings, Inc. reports total compensation of $521,754 for Ian Chan in fiscal 2024, including a base salary of $521,754. Disclosed compensation is on record for 2 fiscal years. Abpro Holdings, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Abpro Holdings, Inc. includes Jin Wook (Miles) Suk (CEO and Chairman), M. Fatih Karatas (CEO and Board Member), Shahraab Ahmad (CFO) and 7 others.